InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.05
-0.07 (-0.58%)
Nov 10, 2026, 4:08 PM HKT
InnoCare Pharma Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, InnoCare Pharma stock has a consensus rating of "Strong Buy" and an average price target of $18.27. The average 1-year stock price forecast is 51.62% higher than the current stock price, while the lowest is $8.93 (-25.93%) and the highest is $23.14 (+92.03%).
Price Target: $18.27 (+51.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for InnoCare Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 8 | 8 | 8 | 8 |
| Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Reiterates $18.30 | Buy | Reiterates | $18.30 | +51.87% | Nov 9, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $18.31 → $18.90 | Buy | Maintains | $18.31 → $18.90 | +56.85% | Oct 29, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $19.31 | Buy | Maintains | $19.31 | +60.25% | Oct 23, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $18.88 | Buy | Maintains | $18.88 | +56.68% | Aug 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $17.00 | Buy | Maintains | $17.00 | +41.08% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
2.68B
from 2.37B
Increased by 12.90%
Revenue Next Year
2.96B
from 2.68B
Increased by 10.28%
EPS This Year
0.36
from 0.39
Decreased by -8.72%
EPS Next Year
0.18
from 0.36
Decreased by -50.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.